Neutralizing Ability of a Single Domain VNAR Antibody: In Vitro Neutralization of SARS-CoV-2 Variants of Concern
Severe Acute Respiratory Syndrome Coronavirus 2 is the causal pathogen of coronavirus disease 2019 (COVID-19). The emergence of new variants with different mutational patterns has limited the therapeutic options available and complicated the development of effective neutralizing antibodies targeting...
Main Authors: | Blanca J. Valdovino-Navarro, Salvador Dueñas, G. Isaí Flores-Acosta, Jahaziel Gasperin-Bulbarela, Johanna Bernaldez-Sarabia, Olivia Cabanillas-Bernal, Karla E. Cervantes-Luevano, Alexei F. Licea-Navarro |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/20/12267 |
Similar Items
-
Unleashing the power of shark variable single domains (VNARs): broadly neutralizing tools for combating SARS-CoV-2
by: Olivia Cabanillas-Bernal, et al.
Published: (2023-09-01) -
Identification and characterization of IgNAR and VNAR repertoire from the ocellate spot skate (Okamejei kenojei)
by: Jianqing Wen, et al.
Published: (2023-05-01) -
COVID-19 Neutralizing Antibodies in Breast Milk of Mothers Vaccinated with Three Different Vaccines in Mexico
by: Olivia Cabanillas-Bernal, et al.
Published: (2022-04-01) -
Chimeric Peptides from <i>Californiconus californicus</i> and <i>Heterodontus francisci</i> with Antigen-Binding Capacity: A Conotoxin Scaffold to Create Non-Natural Antibodies (NoNaBodies)
by: Salvador Dueñas, et al.
Published: (2023-04-01) -
Intraocular Penetration of a vNAR: In Vivo and In Vitro VEGF165 Neutralization
by: Tanya A. Camacho-Villegas, et al.
Published: (2018-03-01)